Tocqueville Asset Management L.P. Bridge Bio Pharma, Inc. Transaction History
Tocqueville Asset Management L.P.
- $6.27 Billion
- Q3 2024
A detailed history of Tocqueville Asset Management L.P. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Tocqueville Asset Management L.P. holds 17,700 shares of BBIO stock, worth $419,844. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,700
Previous 15,200
16.45%
Holding current value
$419,844
Previous $385,000
16.88%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding BBIO
# of Institutions
291Shares Held
171MCall Options Held
10.4MPut Options Held
2.37M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$599 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$596 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$337 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$295 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$144 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.52B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...